AI-Generated Nutritional Messaging for Colorectal Cancer Survivors
(NLM Trial)
Trial Summary
What is the purpose of this trial?
Colorectal cancer survivors often face unique nutritional challenges and require support in their recovery and long0term health. While human experts have traditionally provided that support, there has been an increase in the use of Large Language Models (LLM) in medicine and in nutrition. The LLM offers a potential supplementary resource for generating personalized nutritional advice, specifically in personalized messaging. However, the efficacy and reliability of these AI-generated messages in comparison to human expert advice remain underexplored specific to this population.This study aims to compare the nutrition-related content generated by popular LLMs-ChatGPT, Claude, Gemini, and Co-Pilot-against messages crafted by human experts. By evaluating the generated content in terms of readability, thematic relevance, medical relevance, perceived effectiveness, and implementation of participants' clinical practice, this research will provide insights into the strengths and limitations of using AI for nutritional guidance in colorectal cancer care.
Research Team
Annie Lin, RD, PhD
Principal Investigator
Hormel Institute
Glen Morris, PhD
Principal Investigator
Hormel Institute
Eligibility Criteria
This trial is for colorectal cancer survivors needing nutritional guidance. Participants should be open to receiving dietary advice from both AI language models and human experts. Specific eligibility criteria are not provided, so it's assumed that there are no major restrictions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive nutrition-related content generated by LLMs and human experts for comparison
Follow-up
Participants are monitored for the effectiveness and implementation of nutrition messages
Treatment Details
Interventions
- Nutritional Language Model
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor